57.07

1.06% 0.60

Pre-market: 58.49 1.42 +2.49%

Revolution Medicines Inc (RVMD)

Overview News Price History Option Chain Financials Why RVMD Down? Discussions Forecast

Revolution Medicines Inc stock is traded at $57.07, with a volume of 828.71K. It is up +1.06% in the last 24 hours and up +13.17% over the past month. Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Previous Close:

$56.47

Open:

$56.25

24h Volume:

828.71K

Relative Volume:

0.73

Market Cap:

$9.60B

Revenue:

$29.52M

Net Income/Loss:

$-519.21M

P/E Ratio:

-17.51

EPS:

-3.26

Net Cash Flow:

$-520.21M

1W Performance:

-1.82%

1M Performance:

+13.17%

6M Performance:

+42.57%

1Y Performance:

+162.63%

1-Day Range:

$56.01

$57.97

1-Week Range:

$53.69

$58.40

52-Week Range:

$20.51

$62.40

Revolution Medicines Inc Stock (RVMD) Company Profile

Name

Revolution Medicines Inc

Sector

Healthcare (1193)

Industry

Biotechnology (683)

Phone

415-766-3638

Address

700 SAGINAW DR, REDWOOD CITY, CA

Employee

490

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

RVMD's Discussions on Twitter

Compare RVMD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RVMD	57.07	9.60B	29.52M	-519.21M	-520.21M	-3.26
VRTX	451.23	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	743.35	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	591.82	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	248.79	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	102.14	24.49B	3.30B	-501.07M	1.03B	11.54

Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-16-24	Reiterated	Needham	Buy
Jul-12-24	Initiated	Barclays	Overweight
Jul-08-24	Initiated	Jefferies	Buy
Apr-12-24	Reiterated	Needham	Buy
Apr-10-24	Upgrade	Raymond James	Outperform → Strong Buy
Mar-11-24	Initiated	Piper Sandler	Overweight
Jan-05-24	Upgrade	BofA Securities	Neutral → Buy
Jan-04-24	Initiated	Wedbush	Outperform
Nov-16-23	Initiated	Raymond James	Outperform
Feb-28-23	Upgrade	JP Morgan	Neutral → Overweight
Dec-14-22	Initiated	Needham	Buy
Oct-21-22	Initiated	Oppenheimer	Outperform
May-20-22	Initiated	BofA Securities	Neutral
Mar-01-22	Upgrade	Stifel	Hold → Buy
Sep-23-21	Initiated	Stifel	Hold
Aug-12-21	Downgrade	Goldman	Buy → Neutral
May-18-21	Initiated	Goldman	Buy
May-21-20	Initiated	H.C. Wainwright	Buy
Mar-09-20	Initiated	Cowen	Outperform
Mar-09-20	Initiated	Guggenheim	Buy
Mar-09-20	Initiated	JP Morgan	Neutral

View All

Revolution Medicines Inc Stock (RVMD) Latest News

Nov 19, 2024

Victory Capital Management Inc. Sells 104,851 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Nov 19, 2024

Nov 16, 2024

Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $61.00 Average Price Target from Brokerages - Defense World

Nov 16, 2024

Nov 15, 2024

Revolution Medicines executive sells shares worth $977,508 By Investing.com - Investing.com Australia

Nov 15, 2024

Revolution Medicines executive sells shares worth $977,508 - Investing.com

Nov 15, 2024

Revolution Medicines' SWOT analysis: stock rises on cancer drug pipeline By Investing.com - Investing.com Australia

Nov 15, 2024

Revolution Medicines' SWOT analysis: stock rises on cancer drug pipeline - Investing.com India

Nov 15, 2024

Nov 13, 2024

Revolution Medicines, Inc. (NASDAQ:RVMD) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Nov 13, 2024

Nov 11, 2024

Revolution Medicines (NASDAQ:RVMD) Reaches New 12-Month HighStill a Buy? - MarketBeat

Nov 11, 2024

HC Wainwright Issues Pessimistic Estimate for RVMD Earnings - MarketBeat

Nov 11, 2024

What is Wedbush's Forecast for RVMD FY2024 Earnings? - MarketBeat

Nov 11, 2024

Nov 09, 2024

Revolution Medicines' general counsel sells $360,000 in stock - Investing.com India

Nov 09, 2024

Revolution Medicines Stock Soars to All-Time High of $60.53 By Investing.com - Investing.com Canada

Nov 09, 2024

Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insight - Yahoo Finance

Nov 09, 2024

Decoding Revolution Medicines Inc (RVMD): A Strategic SWOT Insig - GuruFocus.com

Nov 09, 2024

Nov 08, 2024

Wellington Management Group LLP Reduces Stake in Revolution Medi - GuruFocus.com

Nov 08, 2024

Revolution Medicines' general counsel sells $360,000 in stock By Investing.com - Investing.com UK

Nov 08, 2024

Revolution Medicines Stock Soars to All-Time High of $60.53 - Investing.com

Nov 08, 2024

Earnings call: Revolution Medicines reports on RAS(ON) inhibitors progress By Investing.com - Investing.com Australia

Nov 08, 2024

Nov 07, 2024

Earnings call: Revolution Medicines reports on RAS(ON) inhibitors progress - Investing.com

Nov 07, 2024

HC Wainwright Issues Negative Outlook for RVMD Earnings - MarketBeat

Nov 07, 2024

JPMorgan Chase & Co. Issues Positive Forecast for Revolution Medicines (NASDAQ:RVMD) Stock Price - MarketBeat

Nov 07, 2024